Catalyst Capital Advisors LLC Astrazeneca PLC Transaction History
Catalyst Capital Advisors LLC
- $4.66 Billion
- Q4 2024
A detailed history of Catalyst Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 449 shares of AZN stock, worth $32,489. This represents 0.0% of its overall portfolio holdings.
Number of Shares
449
Previous 36,199
98.76%
Holding current value
$32,489
Previous $2.82 Million
98.97%
% of portfolio
0.0%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,339Shares Held
478MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.55 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$3.04 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.7 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.66 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.38 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $224B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...